Individuals with congenital or acquired prolongation of the QT interval, or long QT syndrome (LQTS), are at risk of life-threatening ventricular arrhythmia 1,2 . LQTS is commonly genetic in origin but can also be caused or exacerbated by environmental factors 1,3 . A missense mutation in the L-type calcium channel Ca V 1.2 leads to LQTS in patients with Timothy syndrome 4,5 . To explore the effect of the Timothy syndrome mutation on the electrical activity and contraction of human cardiomyocytes, we reprogrammed human skin cells from Timothy syndrome patients to generate induced pluripotent stem cells, and differentiated these cells into cardiomyocytes. Electrophysiological recording and calcium (Ca 21 ) imaging studies of these cells revealed irregular contraction, excess Ca 21 influx, prolonged action potentials, irregular electrical activity and abnormal calcium transients in ventricular-like cells. We found that roscovitine, a compound that increases the voltage-dependent inactivation of Ca V 1.2 (refs 6-8), restored the electrical and Ca 21 signalling properties of cardiomyocytes from Timothy syndrome patients. This study provides new opportunities for studying the molecular and cellular mechanisms of cardiac arrhythmias in humans, and provides a robust assay for developing new drugs to treat these diseases.
Individuals with congenital or acquired prolongation of the QT interval, or long QT syndrome (LQTS), are at risk of life-threatening ventricular arrhythmia 1, 2 . LQTS is commonly genetic in origin but can also be caused or exacerbated by environmental factors 1, 3 . A missense mutation in the L-type calcium channel Ca V 1.2 leads to LQTS in patients with Timothy syndrome 4, 5 . To explore the effect of the Timothy syndrome mutation on the electrical activity and contraction of human cardiomyocytes, we reprogrammed human skin cells from Timothy syndrome patients to generate induced pluripotent stem cells, and differentiated these cells into cardiomyocytes. Electrophysiological recording and calcium (Ca 21 ) imaging studies of these cells revealed irregular contraction, excess Ca 21 influx, prolonged action potentials, irregular electrical activity and abnormal calcium transients in ventricular-like cells. We found that roscovitine, a compound that increases the voltage-dependent inactivation of Ca V 1.2 (refs 6-8) , restored the electrical and Ca 21 signalling properties of cardiomyocytes from Timothy syndrome patients. This study provides new opportunities for studying the molecular and cellular mechanisms of cardiac arrhythmias in humans, and provides a robust assay for developing new drugs to treat these diseases.
The risk of sudden death due to genetic and drug-induced LQTS is a major concern for patients, clinicians and pharmaceutical companies. Genetic LQTS has an estimated prevalence of 1 in 7,000 individuals and results from mutations in at least 10 genes 1, 4, 5, [9] [10] [11] [12] . Drug-induced LQTS is a side effect of many approved drugs and is a common cause of drug failure in clinical trials. Despite our knowledge of many of the genes that cause LQTS, the mechanisms that underlie the disease in humans are incompletely understood. Mouse models of human LQTS have proved to be problematic because the mouse resting heart rate is approximately tenfold faster than that of humans and therefore mouse cardiomyocytes have different electrical properties than their human counterparts. Therefore it is essential to develop models of LQTS that use human cardiomyocytes. Ca V 1.2 is the main L-type channel in the mammalian heart and is essential for generating the cardiac action potential and for excitation contraction coupling [13] [14] [15] . Ca 21 influx through L-type channels in the plasma membrane causes Ca 21 release through ryanodine receptors in the sarcoplasmic reticulum, leading to muscle contraction [14] [15] [16] [17] . A single amino acid substitution in exon 8a of CACNA1C, the gene encoding Ca V 1.2 in humans, causes Timothy syndrome, a disorder characterized by LQTS, syndactyly (webbing of fingers and toes), immune deficiency and autism 4 . Exon 8a is an alternatively spliced exon of Ca V 1.2, and the Timothy syndrome mutation is a glycine to arginine (G to R) substitution that impairs inactivation of the channel 4, 5, 18, 19 . Ca V 1.2 channels undergo both voltage-dependent inactivation and Ca 21 -dependent inactivation, and the G406R mutation severely impairs voltage-dependent inactivation and subtly affects Ca 21 -dependent inactivation. Precisely how this leads to LQTS or arrhythmias in humans is not known.
To generate induced pluripotent stem cells (iPSCs) from Timothy syndrome patients, we first obtained dermal fibroblasts from two patients by punch biopsy. We confirmed the presence of the Timothy syndrome mutation in these cells by sequencing the genomic DNA using two primer sets that recognize exon 8a in CACNA1C (ref. 4) . We next reprogrammed the fibroblasts to generate iPSCs using four retroviruses containing SOX2, OCT3/4 (also known as POU5F1), KLF4 and MYC (refs 20, 21) . Three to four weeks after the infection, we picked human embryonic stem cell (hESC)-like colonies based on their morphology and expanded them for characterization and in vitro differentiation into cardiac cells ( Fig. 1a ). We generated a total 16 iPSC lines from two Timothy syndrome patients, and 10 control lines from two unrelated individuals without Timothy syndrome.
We selected five Timothy syndrome and five control iPSC lines for further characterization and generation of cardiomyocytes (Supplementary Table 1 ). We used genomic sequencing to confirm that the Timothy syndrome iPSCs preserved the Timothy syndrome mutation ( Supplementary Fig. 1 ), and we mapped the integration sites of the retroviruses using nested polymerase chain reaction (PCR) 22 (Supplementary Table 1 ). We found that all the lines had independent retroviral insertion sites and that the sites did not occur in the coding region of any gene. To examine whether the iPSC lines express human embryonic stem cell markers, we used immunocytochemistry to look for NANOG and TRA2-49-6E (alkaline phosphatase) expression, and found that all of the lines expressed these markers ( Supplementary Fig. 2 ). We also used reverse transcriptase PCR (RT-PCR) to confirm that iPSCs expressed NANOG and Rex-1 and that they had silenced the exogenous genes that were used for reprogramming ( Supplementary Fig. 3 ). In addition, we performed genome-wide microarray analyses of the cells and found that the gene expression patterns of iPSCs closely resembled those of hESCs and not of fibroblasts or neurons (GEO database http:// www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token5jncfzcucugewaha&acc5 GSE25542). We also karyotyped the iPSC lines to ensure that they did not have large chromosomal abnormalities ( Fig. 1b and Supplementary Table 1 ) and injected them into immunodeficient mice to verify that they could generate teratomas. Both control and Timothy syndrome iPSCs were able to form tissues derived from all three germ layers including neural tissues (ectoderm), cartilage (mesoderm) and gut-like epithelium (endoderm) ( Supplementary Fig. 2 and Supplementary Table 1 ), indicating that the iPSCs that we have generated are pluripotent.
To generate human cardiomyocytes from iPSCs, we first prepared embryoid bodies (EBs) from five control and five Timothy syndrome iPSC lines. After one week in suspension culture (day 7), we placed ,80 EBs onto gelatin-coated 100-mm dishes to allow EBs to attach. Thirty days (day 37) after plating, we observed that ,0.5-20% of the EBs showed rhythmic contractions ( Fig. 1c ). There were no significant differences in the number of contracting EBs formed from control and Timothy syndrome iPSC lines (data not shown). RT-PCR analysis revealed that the spontaneously contracting EBs expressed cardiac markers ( Fig. 1d ) and both exons 8 and 8a of CACNA1C but not NANOG, indicating that these contain cardiomyocytes but not iPSCs.
To examine the contractile properties of cardiomyocytes we collected time-lapse images of spontaneously contracting EBs and analysed their movement using image analysis software (Supplementary Movies 1-4 and Fig. 1e , f). We collected movies of 113 EBs derived from five Timothy syndrome iPSC lines and compared them to EBs derived from the five control lines. Control EBs contracted at approximately 60 beats per minute (b.p.m.), similar to the resting heart rate in humans, whereas the Timothy syndrome cardiomyocytes contracted at only ,30 b.p.m. Contraction of the Timothy syndrome EBs was significantly more irregular than contraction of control cardiomyocytes ( Fig. 1e , g). This was reflected in the broader distribution of intercontraction intervals in Timothy syndrome EBs relative to those of controls ( Fig. 1h ). These results indicate that contracting EBs from multiple iPSC lines from two Timothy syndrome patients have disease-specific defects.
To characterize the underlying defects in cardiomyocytes from Timothy syndrome patients further, we dissociated contracting EBs into single cells. We stained these cells with antibodies that recognize the cardiac markers a-actinin, which is present at the Z-line of the sarcomere, and cardiac troponin I, which is a cardiac-specific myofilament protein ( Fig. 2a and Supplementary Fig. 4 ). More than 65% of the cells from the beating EBs expressed both proteins and had well-organized sarcomeres. There were no differences in the staining pattern of Timothy syndrome and control cardiomyocytes. We next used wholecell patch clamping to determine whether the Timothy syndrome mutation altered L-type channel voltage-dependent inactivation in human cardiomyocytes. We measured L-type-channel-generated currents using Ba 21 as the charge carrier and found that the L-type channel current in Timothy syndrome cardiomyocytes had significantly reduced voltage-dependent inactivation compared to control cells ( Fig. 2b-e and Supplementary Fig. 4 ). This was apparent both from the increased amplitude of the residual current after a 350-ms depolarization and from increased current elicited by a 300-ms test pulse after a 2-s depolarizing pulse to different voltages. In contrast, there was no difference between control and Timothy syndrome cardiomyocytes in the current-voltage relationship or the peak amplitudes of Ba 21 currents (Fig. 2d ). These results are broadly consistent with the properties of the Timothy syndrome mutant channel observed in heterologous expression systems 4, 18, 19 .
Ca 21 influx through L-type channels contributes to the plateau phase of the cardiac action potential, so we asked whether the shape or duration of the action potential in cardiomyocytes was altered by the Timothy syndrome mutation. Using current-clamp recording, we examined spontaneous action potentials in control and Timothy syndrome cardiomyocytes. Because human cardiomyocyte populations generated from iPSCs contain nodal-like, ventricular-like and atriallike myocytes 23, 24 , we harvested the mRNA from each patch-clamped cardiomyocyte and used single-cell RT-PCR of cardiac ventricular myosin light chain 2v (MLC2v, Supplementary Fig. 5 ) to identify ventricular cells. We found that ventricular-like myocytes from Timothy syndrome patients had action potentials that were three times as long as those of control cells ( Fig. 2f, g ). In addition, the Timothy syndrome cardiomyocytes exhibited a large number of depolarizing events that failed to trigger a full action potential. These depolarizations were similar to the delayed afterdepolarizations (DADs) that arise after ectopic release of Ca 21 from the sarcoplasmic reticulum and which are associated with cardiac arrhythmias (Fig. 2f , h). In contrast we did not find significant differences in the action potential properties of nodal-like and atrial-like myocytes from control and Timothy syndrome patients ( Supplementary Fig. 5 ). These findings indicate that ventricular cardiomyocytes derived from Timothy syndrome iPSCs are defective and provide a possible cellular basis for LQTS and arrhythmia in these patients.
Ca V 1.2 channels have a crucial role in activating Ca 21 -induced Ca 21 release from the sarcoplasmic reticulum but the effect of altering Ca V 1.2 inactivation on this process is not known. We therefore asked how the Timothy syndrome mutation affects Ca 21 signalling in Timothy syndrome cardiomyocytes. We used a confocal microscope to perform fast line-scan imaging of human cardiomyocytes loaded with the Ca 21 indicator Fluo-4. The Ca 21 elevations in spontaneously contracting Timothy syndrome cardiomyocytes were more irregular than those of control cardiomyocytes ( Fig. 3 and Supplementary Fig. 6 ). In addition, the Timothy syndrome mutation led to significantly larger and more prolonged Ca 21 
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inactivation is important for maintaining the timing and the amplitude of the ventricular Ca 21 release.
The finding that cardiomyocytes from Timothy syndrome patients have disease-specific electrical defects indicates that they might be a useful system for testing possible therapeutic compounds. As a proof of principle, we investigated whether roscovitine, a cyclin-dependent kinase inhibitor that increases voltage-dependent inactivation in HEK 293 cells expressing Ca V 1.2 channels 6-8 , could rescue the phenotypes of Timothy syndrome cardiomyocytes. We examined the effect of three different concentrations of roscovitine (10, 33.3 and 100 mM) on the timing and amplitude of spontaneous Ca 21 transients in Timothy syndrome cardiomyocytes. Treatment with 100 mM roscovitine completely eliminated contractions but 33.3 mM roscovitine significantly reduced both the irregular timing and amplitude of Ca 21 transients (Fig. 4a, b and Supplementary Fig. 7 ). Washing out roscovitine partially restored the irregular Ca 21 transients in Timothy syndrome cardiomyocytes but this effect did not reach significance [6] [7] [8] .
To determine if roscovitine rescues the electrophysiological properties of Timothy syndrome cardiomyocytes, we used whole-cell patch clamping to measure Ca V 1.2 currents and action potentials in Timothy syndrome cardiomyocytes in the presence and absence of roscovitine. Roscovitine significantly increased Ca V 1.2 voltage-dependent inactivation in Timothy syndrome cardiomyocytes ( Fig. 4c, d ) but had only a mild effect on control cardiomyocytes ( Supplementary Fig. 8 ). Roscovitine also reduced the duration of action potentials in Timothy syndrome cardiomyocytes and decreased the frequency of abnormal depolarizing events (Fig. 4e, f) . These results indicate that cardiomyocytes from patients with LQTS can be used to screen potential drugs, and suggest that drugs related to roscovitine might be valuable tools for treating Timothy syndrome and other cardiac arrhythmias.
We have developed a new in vitro model for studying cardiac arrhythmias that has important advantages relative to existing approaches 25 . In contrast to mouse cardiomyocytes, iPSC-derived EBs spontaneously contract at a rate that is similar to that of the human heart, and single cells derived from these EBs have structural and electrical properties that are similar to those of cardiomyocytes from human patients. Importantly, cardiomyocytes derived from five different iPSC lines from two independent patients with LQTS had cellular defects that are consistent with the cardiac defects of the patients. The EBs from Timothy syndrome patients contracted slowly relative to control EBs, consistent with bradycardia in many Timothy syndrome patients. Ventricular cardiomyocytes from Timothy syndrome patients also had prolonged action potentials that probably delay the repolarization of the heart and lead to LQTS. Both the isolated cardiomyocytes and the EBs contracted arrhythmically and the cardiomyocytes had There were no significant differences in the peak amplitude of Ba 21 currents between control and Timothy syndrome cardiomyocytes (data not shown). e, Ba 21 current in control and Timothy syndrome myocytes stimulated with a test pulse to 110 mV after a family of prepulses from 2110 to 130 mV in 10-mV increments (raw traces in Supplementary Fig. 4c ; control, n 5 23 cells in 4 lines; Timothy syndrome, 
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frequent depolarizing events that failed to produce action potentials and were similar to DADs.
The phenotype of Timothy syndrome cardiomyocytes stands in contrast to the phenotype of cardiomyocytes from patients with LQTS1 (ref. 12) . Only ventricular cardiomyocytes from Timothy syndrome patients had prolonged action potentials, whereas both ventricular-and atrial-like cardiomyocytes from LQTS1 had this phenotype. Furthermore, arrhythmias and delayed depolarizations were observed in spontaneously beating Timothy syndrome cardiomyocytes whereas they could only be elicited in LQTS1 cardiomyocytes by stimulation with isoproterenol. Although it is difficult to link these features to the torsade de points and to ventricular fibrillations in Timothy syndrome patients, these findings set the stage for the development of more sophisticated models of LQTS. Finally, this study demonstrates that iPSC-derived cardiomyocytes are a useful platform for identifying drug candidates. Roscovitine restored the action potential duration in Timothy syndrome cardiomyocytes and prevented the occurrence of arrhythmias. Even though roscovitine has other targets 26 it could be a useful lead compound for the development of new types of antiarrhythmics.
METHODS SUMMARY
Control and Timothy syndrome iPSC lines were generated using retroviral infection with pMXs-SOX2, pMXs-OCT3/4, pMXs-MYC and pMXs-KLF4 expression plasmids (Addgene) generated by S. Yamanaka's group 20 . The iPSCs were cultured on irradiated DR4 mouse embryonic fibroblast feeders using standard ES media with 10-15 ng ml 21 bFGF (R & D Systems), and cells were passaged with dispase (3 unit ml 21 , Invitrogen). The G1216A substitution in exon 8a was detected by sequencing of PCR products from DNA harvested from fibroblasts and iPSC lines using primers for human Ca V 1.2 exon 8a. Immunocytochemistry, RT-PCR, microarray, karyotyping and teratoma formation assay were performed using standard protocols. For in vitro generation of cardiomyocytes, embryoid bodies were cultured with Wnt3a (100 ng ml 21 , R&D Systems) 27 . Whole-cell patch clamp recordings in single cardiomyocytes were conducted using standard methods. Live-cell Ca 21 
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METHODS
Cell culture. HEK 293T cells were cultured in Dulbecco's Modified Eagle Media (DMEM) supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 unit ml 21 penicillin and 100 mg ml 21 of streptomycin (all from Invitrogen). Human fibroblasts were maintained in Minimum Essential Medium, Eagle (MEME, ATCC) containing 10% FBS, 100 unit ml 21 penicillin and 100 mg ml 21 of streptomycin. The patient fibroblasts were obtained by punch biopsy following a protocol approved by the Stanford Institutional Review Board (IRB). Human iPSCs were cultured on irradiated DR4 mouse embryonic fibroblast feeders using DMEM/F12 (1:1) medium containing 20% knockout SR, 1 mM non-essential amino acids (all from Invitrogen), 3 mM L-glutamine, 0.1 mM b-mercaptoethanol (Sigma-Aldrich), 100 unit ml 21 penicillin and 100 mg ml 21 streptomycin and 10-15 ng ml 21 bFGF (R & D Systems). Human cardiomyocytes generated from iPSCs were maintained in EB5 media: DMEM/F12 with GlutaMAX (Invitrogen) containing 5 % FBS, 1 mM non-essential amino acids, 1 mM L-glutamine, 0.1 mM b-mercaptoethanol, 100 unit ml 21 penicillin and 100 mg ml 21 streptomycin. Plasmids. pMXs-SOX2, pMXs-OCT3/4, pMXs-MYC and pMXs-KLF4 expression plasmids were generated by S. Yamanaka's group 20 and were obtained from Addgene. The pUMVC packaging plasmid and pCMV-VSV-G envelope plasmids were used to prepare the retroviruses. A retrovirus encoding yellow fluorescent protein (YFP) was generated to examine the infection efficiency of human fibroblasts. pMXs-YFP was amplified using Taq polymerase, subcloned into the vector fragment of pMXs-OCT3/4, digested with EcoRI and verified by sequencing. iPSC generation with retroviral infection. To prepare the retroviruses, HEK 293T cells were plated at 6-8 3 10 5 cells per well in 6-well plates coated with 20 mg ml 21 of poly-ornithine. Twenty-four hours after plating, the cells were transfected with pMXs plasmids containing the coding sequences for YFP, SOX2, OCT3/4, MYC or KLF4, along with pUMVC and pCMV-VSV-G plasmids at the ratio of 2.125 mg of plasmid DNA to 5 ml of Lipofectamine2000 in 500 ml OpiMEM (both from Invitrogen). The ratio of pMXs:pUMVC:pCMV-VSV-G was 8:8:1. Twenty-four hours after transfection, the DMEM media was replaced with fibroblast (MEME) media. The next day the culture media containing the retroviruses was harvested and mixed 1:1 with 0.6 mg ml 21 polybrene (Sigma-Aldrich). The cell debris in the mixtures was removed using 0.45 mm lowprotein-binding filters (Nalgene). The patient and human fibroblasts were plated at 1 3 10 5 cells per well in 6-well plates one day before infection with the retroviruses. The retrovirus solution was added to the fibroblasts for 8 h per day for 4 days to reduce cell death. The viruses were prepared fresh for each infection. To prevent cell crowding which can inhibit cell growth, the infected fibroblasts were passaged every other day with a dilution ratio of 1:3. Six days after the first infection, infected fibroblasts were plated at 1-50 3 10 3 cells per dish in gelatin-coated 100 mm dishes containing ,1.5 3 10 6 irradiated DR4 feeder cells per dish. The density of infected cells on feeders was critical for successful reprogramming so cells were always seeded at three different densities. One day after plating on DR4 feeder cells, the media was changed to human iPSC media made as described above. Human ES-like colonies were observed 21-30 days after the initial infection. These colonies were treated with 3 unit ml 21 dispase (Invitrogen) for 10 min at 37 uC and washed three times with iPSC media, before being mechanically isolated with 22G needles under a microscope for subcloning. iPSC characterization. The Timothy syndrome mutation in patient-derived cells was confirmed using DNA sequencing. Genomic DNA was isolated using DNeasy Blood and Tissue Kit (Qiagen) and the region encoding CACNA1C exon 8a was amplified using PCR and the primer set: forward 59-TACACTAATCAT CATAGGGTCAT-39; reverse 59-TAGCGATTCCCAGTTTAGGTAC-39. The PCR product (,1.2 kb) was purified using the QIAquick PCR purification kit (Qiagen) and directly sequenced using the original forward primer and a new reverse primer (Ori-R-MY): 59-CTCAGAGATAGACTGCTCAGTCTATG-39.
To investigate the number and site of viral integration in iPSC genome we used nested PCR to amplify iPSC genomic DNA treated with BamHI 1 BglII or PstI as has been previously described 22 . The primer sets used are shown in Supplementary  Table 2 . The PCR products were purified and direct-sequenced or subcloned into pCR4-TOPO vector (Invitrogen).
To examine the expression of pluripotent markers, we placed the iPSCs on 15-mm round coverslips (Warner Instruments, CS-15R) coated with Matrigel (BD Biosciences) in 24-well plates. The iPSCs were fixed using 4% paraformaldehyde (PFA, Electron Microscopy Sciences, EM grade), 2% sucrose in PBS for 20 min at room temperature and washed three times with PBS. The cells were then blocked overnight with a solution containing 5% donkey serum (Calbiochem), 1%bovine serum albumin (BSA, Sigma-Aldrich) and 0.1% Triton X-100 (Sigma-Aldrich) in PBS for anti-NANOG staining or with a solution containing 3% BSA and 0.25% Triton X-100 in PBS for anti-TRA-2-49/6E antibody staining. The samples were then washed six times using PBS and incubated with the anti-NANOG (1/20 dilution in the NANOG blocking solution; R&D Systems) and TRA-2-49/6E antibodies (1/80 dilution in the blocking solution without any detergents; the antibody developed by P. W. Andrews was obtained from Development Studies Hybridoma Bank developed under the auspices of the NICHD and maintained in the University of Iowa, Department of Biological Sciences) for at least 24 h at 4 uC. After incubation with primary antibodies, samples were washed six times (5 min each), and incubated in secondary antibody, Alexa Fluor 594 (Molecular Probes, 2 mg ml 21 ), for 30 min at room temperature, washed with PBS six times (5 min each), stained with Hoechst 33285 (Molecular Probes, 1/10,000 dilution in PBS) and mounted on slides (Becton, Dickinson) using Aqua Poly/Mount (Polysciences). Images were acquired using a 310 (NA 5 0.5) objective lens or 340 (NA 5 1.3) oil immersion objective lens (Nikon) on the stage of a Nikon Eclipse TE2000U inverted microscope.
Karyotyping of iPSCs was achieved using standard protocols. For RT-PCR, RNA from fibroblasts and iPSCs was prepared using the RNeasy Mini kit and RNase-Free DNase set (Qiagen). cDNA was synthesized from 1 mg RNA using the SuperScript III First-Strand Synthesis System for RT-PCR (Invitrogen). The cDNA (21 ml) was diluted with DNase-free water (Invitrogen) at 1:5 and 1 ml of the samples was used for conventional RT-PCR with AccuPower PCR PreMix (Bioneer, K-2016) using primer sets (Supplementary Table2). For quantitative RT-PCR, FastStart Universal SYBR Green Master (Rox, Roche) and Mastercycler ep realplex (Eppendorf) were used. Teratoma formation assays. Teratoma formation experiments were performed by injecting subcutaneously ,1 3 10 6 cells in 50% Matrigel and 10 mM Y-27632 (Calbiochem) in iPSC media (,1 3 10 7 cell ml 21 ) into 8-week-old severe combined immunodeficient (SCID) beige mice (Charles River Laboratories). The mice were killed ,8 weeks after injection, the tumours were dissected, fixed with PBS containing 4% PFA and 10-30% sucrose and embedded in Tissue-Tek OCT compound (Sakura Finetek). Sections were stained with Haematoxylin 7211 and Eosin-Y (Thermo Scientific). All animal protocols and handling for the teratoma formation assay were performed following the guidelines established by Stanford University Administrative Panel on Laboratory Animal Care (APLAC) Committee. Differentiation of iPSCs into cardiomyocytes. iPSCs in 6-well plates (Falcon, 353046) were treated with 3 unit ml 21 of dispase for ,20 min at 37 uC to detach the colonies completely. The colonies were collected by allowing the iPSCs colonies settle to the bottom of the 50 ml tubes for ,6 min. The iPSC colonies were then washed and placed in Ultra-low 100-mm dishes (Corning Life Sciences) with iPSC media containing 10 mM Y-27632 without bFGF to form embryoid bodies. The next day the media was changed to EB20 with Wnt3a (DMEM/F12 with GlutaMAX containing 20% FBS, 1 mM non-essential amino acids, 1 mM L-glutamine, 0.1 mM b-mercaptoethanol, 100 unit ml 21 penicillin, 100 mg ml 21 streptomycin and 100 ng ml 21 Wnt3a (R&D Systems 27 )). Between days three and six, the media was changed to EB20 media without Wnt3a and media replaced every other day. At day 7, the EBs (,80 per dish) were plated into 100-mm dishes (BD Biosciences) coated with gelatin in EB5 media as described above. During days 7-37, the media was changed daily, and at around day 17 some of the EBS were observed to contract spontaneously. At day 37, EBs were isolated mechanically using a 22G needle, placed into 15-ml tubes, washed with PBS once, centrifuged (1,000 r.p.m., 2 min) and incubated in 0.25% trypsin and 0.03% EDTA (Invitrogen) for 4 min at room temperature with gentle shaking. EB5 media was then added to the tube, the cells were isolated by centrifugation and washed before using 1 ml of EB5 media and a P1000 filter tip (,30 times) to dissociate the EBs into single cells. The cells were plated on gelatin-coated 15-mm round coverslips in 24-well plates or 4-well LAB-TEK II chambers (Nalge Nunc International, chamber #1.5 German coverglass system). A single EB was sufficient for a few coverslips or wells of a chamber. For about 7 days after dissociation, cells were observed without conducting experiments, to ensure that the coverslips and chambers were not contaminated with fast-growing cell populations such as fibroblast-like cells and progenitors. The antibodies to cardiac Troponin I (clone 284, 1/200 dilution, Abcam) and a-actinin (clone EA-53, 1/200 dilution, Sigma-Aldrich) were used to characterize the dissociated cardiomyocytes. Analysis of cardiomyocytes contraction. Images were collected at a rate of 5 frames per second using OpenLab software (Perkin Elmer) and converted to multiframe TIFF images for analysis using the Image Processing Toolbox in MATLAB R2009b (Mathworks). Relative motion between successive frames was quantified by subtracting each frame from the preceding frame and summing across all pixels. Movement was calculated by plotting the relative motion over time. Contractions were detected as a peak of relative motion and a second, typically smaller peak, corresponded to the relaxation of the EBs. Peaks were selected manually and the length of time between contractions was measured. Rhythmicity was measured by calculating the ratio of the standard deviation to the mean of the intervals between contractions. The threshold for classifying an EB LETTER RESEARCH
